lung cancer

Authors and Affiliations:

Sara Granja ^1,2, Ibtissam Marchiq ³, Renaud Le Floch ³, Conceição Souto Moura ^5,6, Fátima Baltazar ^1,2,* and Jacques Pouysségur ^3,4

¹ Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal

² ICVS/3B’s-PT Government Associate Laboratory, Braga/ Guimarães, Portugal

Colorado Convention Center, Denver, Colorado, USA

6 - 9 September, 2015

See more informations here: https://www.iaslc.org/events/16th-world-conference-lung-cancer

Colorado Convention Center, Denver, Colorado, USA

6 - 9 September, 2015

See more informations here: https://www.iaslc.org/events/16th-world-conference-lung-cancer

Palexpo, Geneva, Switzerland

15 - 18 April, 2015

See more informations here: http://www.esmo.org/Conferences/ELCC-2015-Lung-Cancer

Palexpo, Geneva, Switzerland

15 - 18 April, 2015

See more informations here: http://www.esmo.org/Conferences/ELCC-2015-Lung-Cancer

The review highlights the putative role of a marker of squamous differentiation in lung cancer for differential diagnosis on small biopsies and cytology specimens.

Authors and e affiliations:

Nobre AR, Albergaria A, Schmitt F.

Source

Cancer Genetics Group, Institute of Molecular Pathology and Immunology of Porto University (IPATIMUP), Porto, Portugal

Abstract:

Esta revisão chama a atenção para um marcador de diferenciação epidermóide em cancro de pulmão que pode ser utilizado em citologia e pequenas biópsias, e que é fundamental para o estabelecimento de uma terapêutica adequada.

Resumo:

«p40: A p63 Isoform Useful for Lung Cancer Diagnosis - A review of the Physiological and Pathological Role of p63»